← Evidence map

ArticleAnnals of translational medicine2021

The addition of radiofrequency ablation for patients receiving sorafenib: new evidence for a new standard?

Michael Lock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 33553296